No direct correlation between mutant frequencies and cancer incidence induced by MeIQ in various organs of Big Blue® mice

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 400, Issue 1-2, 1998, Pages 251-257

  Nagao, Minako ^a   Fujita, Hirofumi ^b   Ochiai, Masako ^a   Wakabayashi, Keiji ^a   Sofuni, Toshio ^c   Matsushima, Taijiro ^b   Sugimura, Takashi ^a   Ushijima, Toshikazu ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b Japan Bioassay Laboratory   (Japan)

^c NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

2 amino 3,4 dimethylimidazo 4,5 f quinoline; BBM, Big Blue mouse; CI, cancer incidence; HCC, hepatocellular carcinoma; MeIQ; MF, mutant frequency

Indexed keywords

2 AMINO 3,4 DIMETHYLIMIDAZO[4,5 F]QUINOLINE; CARCINOGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INCIDENCE; CANCER SURVIVAL; CARCINOGENICITY; CECUM CANCER; COLON ADENOCARCINOMA; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; INTESTINE CELL; INTESTINE TUMOR; LIVER CELL CARCINOMA; MOUSE; MOUSE STRAIN; MUTATION RATE; NONHUMAN; PRIORITY JOURNAL; REPRESSOR GENE;

ANIMALS; BACTERIAL PROTEINS; ESCHERICHIA COLI PROTEINS; FEMALE; INCIDENCE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTAGENS; NEOPLASMS, EXPERIMENTAL; QUINOLINES; REPRESSOR PROTEINS;

EID: 0343031051     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(98)00032-3     Document Type: Article

References (25)

1. [1] K. Wakabayashi, M. Nagao, H. Esumi, T. Sugimura, Food-derived mutagens and carcinogens, Cancer Res. 52 (1992) 2092-2098.
2. [2] T. Sugimura, Overview of carcinogenic heterocyclic amines, Mutation Res. 376 (1997) 211-219.
3. [3] M. Nagao, T. Sugimura, Carcinogenic factors in food with relevance to colon cancer development, Mutation Res. 290 (1993) 43-51.
4. [4] T. Kato, H. Ohgaki, H. Hasegawa, S. Sato, S. Takayama, T. Sugimura, Carcinogenicity in rats of a mutagenic compound, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline, Carcinogenesis 9 (1988) 71-73.
5. [5] H. Ohgaki, H. Hasegawa, M. Suenaga, T. Kato, S. Sato, S. Takayama, T. Sugimura, Induction of hepatocellular carcinoma and highly metastatic squamous cell carcinomas in the forestomach of mice by feeding 2-amino-3,4-dimethylimidazo[4,5-f]quinoline, Carcinogenesis 7 (1986) 1889-1893.
6. [6] S.W. Kohler, G.S. Provost, A. Fieck, P.L. Kretz, W.O. Bullock, J.A. Sorge, D.L. Putman, J.M. Short, Spectra of spontaneous and mutagen induced mutations in the lad gene in transgenic mice, Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 7958-7962.
7. [7] N.J. Gorelick, K.R. Tindall, B.W. Glickman, Introduction: State of the art in transgenic animals in mutation research, Environ. Mol. Mutagen. 28 (1996) 295-298.
8. [8] K.W. Kinzler, B. Vogelstein, Lessons from hereditary colorectal cancer, Cell 87 (1996) 159-170.
9. [9] T. Sugimura, Multistep carcinogenesis: a 1992 perspective, Science 258 (1992) 603-607.
10. [10] T. Suzuki, M. Hayashi, M. Ochiai, K. Wakabayashi, T. Ushijima, T. Sugimura, M. Nagao, T. Sofuni, Organ variation in the mutagenicity of MeIQ in Big Blue® lacI transgenic mice, Mutation Res. 369 (1996) 45-49.
11. [11] L.G. Lajtha, Stem cell concepts, in: C.S. Potten (Ed.), Stem Cells, Churchill Livingstone, Edinburgh, 1983, pp. 1-11.
12. [12] S.H. Sigal, S. Brill, A.S. Fiorino, L.M. Reid, The liver as a stem cell and lineage system, Am. J. Physiol. 263 (1992) G139-G148.
13. [13] S.J. Morrison, N.M. Shah, D.J. Anderson, Regulatory mechanisms in stem cell biology, Cell 88 (1997) 287-298.
14. [14] J.M. Wilson, Round two for liver gene therapy, Nat. Genet. 12 (1996) 232-233.
15. [15] A.G. Knudson, A.T. Meadows, W.W. Nichols, R. Hill, Chromosomal deletion and retinoblastoma, New Engl. J. Med. 295 (1976) 1120-1123.
16. [16] S. Hirohashi, Pathology and molecular mechanisms of multistage human hepatocarcinogenesis, in: C.C. Harris, S. Hirohashi, N. Ito, H.C. Pitot, T. Sugimura, M. Terada, J. Yokota (Eds.), Multistage Carcinogenesis, Proceedings of the 22nd International Symposium of The Princess Takamatsu Cancer Research Fund, Japan Scientific Societies Press, Tokyo, 1992, pp. 87-93.
17. [17] W.F. Dietrich, E.S. Lander, J.S. Smith, A.R. Moser, K.A. Gould, C. Luongo, N. Borenstein, W. Dove, Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse, Cell 75 (1993) 631-639.
18. Min-induced intestinal neoplasia, Cell 81 (1995) 957-966.
19. [19] J.T. Evans, T.S. Hauschka, A. Mittelman, Brief Communication: Differential susceptibility of four mouse strains to induction of multiple large-bowel neoplasms by 1,2-dimethyl-hydrazine, J. Natl. Cancer Inst. 52 (1974) 999.
20. [20] B.A. Diwan, K.E. Blackman, Differential susceptibility of 3 sublines of C57BL/6 mice to the induction of colorectal tumors by 1,2-dimethylhydrazine, Cancer Lett. 9 (1980) 111-115.
21. [21] M. Ochiai, M. Watanabe, H. Kushida, K. Wakabayashi, T. Sugimura, M. Nagao, DNA adduct formation, cell proliferation and aberrant crypt focus formation induced by PhIP in male and female rat colon with relevance to carcinogenesis, Carcinogenesis 17 (1996) 95-98.
22. [22] H. Okonogi, G.R. Stuart, E. Okochi, T. Ushijima, T. Sugimura, B.W. Glickman, M. Nagao, Effect of gender and species on spectra of mutation induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in the lacI transgene, Mutation Res. 395 (1997) 93-99.
23. [23] N. Ito, R. Hasegawa, M. Sano, S. Tamano, H. Esumi, S. Takayama, T. Sugimura, A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), Carcinogenesis 12 (1991) 1503-1506.
24. [24] V. de Annemieke, M.E.T. Dollé, J.L.M. Broekhof, J.J.A. Muller, E.D. Kroese, C.F. van Kreijl, P.J.A. Capel, J. Vijg, H. van Steeg, Induction of DNA adducts and mutations in spleen, liver and lung of XPA-deficient/ lacZ transgenic mice after oral treatment with benzo[a]pyrene: correlation with tumour development, Carcinogenesis 18 (1997) 2327-2332.
25. [25] A. Hakura, Y. Tsutsui, J. Sonoda, J. Kai, T. Imade, M. Shimada, Y. Sugihara, T. Mikami, Comparison between in vivo mutagenicity and carcinogenicity in multiple organs by benzo[a]pyrene in the lacZ transgenic mouse (Muta™Mouse), Mutation Res. 398 (1998) 123-130.